CDK4/6 inhibitor-statin interaction and rhabdomyolysis in breast cancer treatment: a case-based systematic review.

João RB, Soares LR, Ragazzo PC, Freitas-Junior R

Open source

DOI
10.1007/s00280-026-04913-w
Published
2026 Jul 1
Container
Cancer chemotherapy and pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00280-026-04913-w,
  title = {CDK4/6 inhibitor-statin interaction and rhabdomyolysis in breast cancer treatment: a case-based systematic review.},
  author = {João RB and Soares LR and Ragazzo PC and Freitas-Junior R},
  year = {2026},
  journal = {Cancer chemotherapy and pharmacology},
  doi = {10.1007/s00280-026-04913-w},
  url = {https://doi.org/10.1007/s00280-026-04913-w}
}

RIS

TY  - JOUR
TI  - CDK4/6 inhibitor-statin interaction and rhabdomyolysis in breast cancer treatment: a case-based systematic review.
AU  - João RB
AU  - Soares LR
AU  - Ragazzo PC
AU  - Freitas-Junior R
PY  - 2026
JO  - Cancer chemotherapy and pharmacology
DO  - 10.1007/s00280-026-04913-w
UR  - https://doi.org/10.1007/s00280-026-04913-w
ER  - 

APA

RB, J., LR, S., PC, R., & R, F. (2026). CDK4/6 inhibitor-statin interaction and rhabdomyolysis in breast cancer treatment: a case-based systematic review.. Cancer chemotherapy and pharmacology. https://doi.org/10.1007/s00280-026-04913-w

Source records